BioLaurus manages a portfolio of preclinical imaging studies across therapeutic areas — from initial study design consultation through execution, analysis, and regulatory reporting.
F-18 FDG-PET/CT tumor efficacy study in murine xenograft model — quantitative SUV analysis and longitudinal tumor response monitoring.
SPECT/CT cardiac function study for safety pharmacology assessment in rat — answering organ function questions arising from a Phase III clinical program.
PET imaging of mu-opioid receptor occupancy in non-human primates — supporting IND-enabling data package for a novel CNS therapeutic.
Multi-modal MRI and SPECT hepatic function study in NASH mouse model — characterizing drug-induced changes in liver perfusion and metabolism.
Contact BioLaurus to initiate study design, request an RFQ, or brief our team on your preclinical imaging needs.
Founded · San Diego, CA 92106
Contract Research Organization
Accredited Vivarium Network
Multi-Species Imaging Capability